We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stored Blood for Transfusion Is Practical After Heart Surgery

By LabMedica International staff writers
Posted on 01 Nov 2015
Patients often need transfusions of red blood cells to replace the blood they have lost during major surgeries, however, the question of whether stored blood is safe for heart surgery patients has had mixed answers.

Red blood cells (RBCs) or erythrocytes that transport oxygen throughout the body go through several changes while in storage, potentially decreasing their oxygen-carrying ability and until now, it has not been clear as to whether such changes affect patient outcome after receiving transfusions.

Clinical scientists at the Karolinska University Hospital (Stockholm, Sweden) identified all patients who underwent coronary artery bypass graft surgery, heart valve surgery, or both between 1997 and 2012. More...
Transfusion data were obtained from the nationwide register of blood transfusions database. Storage of RBCs was classified with discrete patient groups who had exclusively received blood stored less than 14 days, 14 to 27 days, or 28 to 42 days, and a mixed storage category for patients receiving blood of mixed age. Follow-up was completed on December 31, 2013.

Between 1997 and 2012, 47,071 patients were transfused in connection with cardiac surgery in nine Swedish hospitals. Women constituted 39.2% and the mean ±SD age was 70.0 ±9.7 years. Of these patients, 36.6% exclusively received RBCs stored less than 14 days; 26.8%, RBCs stored 14 to 27 days; 8.9%, RBCs stored 28 to 42 days; and 27.8%, RBCs of mixed age. Most clinical parameters were similar in the groups, although the less common blood groups such as AB and B, were more common with longer storage. Recipients of the freshest blood received more transfusions, 3.1 versus 2. No differences were observed for a range of comorbidities. After investigating patient outcomes, the team found that the use of stored blood units did not influence heart surgery patient outcomes.

Ulrik Sartipy, MD, PhD, the lead author of the study said, “This study is by far the largest investigation focusing on the issue of blood storage in this very sensitive patient group, and we find absolutely no hint of negative health effects associated with stored blood.” The study provides very firm reassurance that the current blood storage practices are safe. The study was published on October 20, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Karolinska University Hospital



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
HPV Test
Allplex HPV28 Detection
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.